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In families with nonsyndromic X-linked mental retardation (NS-XLMR), 130% of mutations seem to cluster on
proximal Xp and in the pericentric region. In a systematic screen of brain-expressed genes from this region in 210
families with XLMR, we identified seven different mutations in JARID1C, including one frameshift mutation and
two nonsense mutations that introduce premature stop codons, as well as four missense mutations that alter
evolutionarily conserved amino acids. In two of these families, expression studies revealed the almost complete
absence of the mutated JARID1C transcript, suggesting that the phenotype in these families results from functional
loss of the JARID1C protein. JARID1C (Jumonji AT-rich interactive domain 1C), formerly known as “SMCX,” is
highly similar to the Y-chromosomal gene JARID1D/SMCY, which encodes the H-Y antigen. The JARID1C protein
belongs to the highly conserved ARID protein family. It contains several DNA-binding motifs that link it to
transcriptional regulation and chromatin remodeling, processes that are defective in various other forms of mental
retardation. Our results suggest that JARID1C mutations are a relatively common cause of XLMR and that this
gene might play an important role in human brain function.
Introduction
Mental retardation (MR), usually defined as cognitive
impairment with an IQ !70, is estimated to affect 2%–
3% of the population in industrialized countries (Roe-
leveld et al. 1997). Etiologically, MR is a very heter-
ogeneous condition that involves environmental, sto-
chastic, and/or genetic factors. Numerous studies of
large families containing males with MR have high-
lighted the importance of the X chromosome. Prevalence
estimates for X-linked mental retardation (XLMR)
range from 0.56/1,000 males for severe forms to 1.83/
1,000 for mild and severe forms (Herbst and Miller
1980; Fishburn et al. 1983). Approximately two-thirds
of male patients with XLMR exhibit a nonsyndromic
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form of XLMR (NS-XLMR) in which MR is the only
clinical manifestation (Fishburn et al. 1983). NS-XLMR
is a very heterogeneous condition. With one exception,
all of the relevant genes identified until 2002 (FMR2
[MIM 309548], OPHN1 [MIM 300127], PAK3 [MIM
300142], GDI1 [MIM 300104], IL1RAPL1 [MIM
300206], TM4SF2 [MIM 300096], ARHGEF6 [MIM
300267], MECP2 [MIM 300005], FACL4 [MIM
300147], and ARX [MIM 300382]; see review by Chelly
and Hamel [2003]) showed mutations only in a very
small proportion of families with XLMR, suggesting
that up to 100 different genes might be involved in NS-
XLMR. In an analysis of linkage intervals found in fam-
ilies examined in published and unpublished studies, we
have recently shown that mutations involved in NS-
XLMR seem to cluster in three different regions of the
human X chromosome (Ropers et al. 2003). Two clus-
ters, one at Xq28 and the other at Xp22.1-p21.3, co-
incide with known MR genes. However, the presence of
a broad peak on proximal Xp argued for the existence
of unknown genes for NS-XLMR in this region. There-
fore, we chose a 7.4-Mb interval in Xp11, flanked by
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the genes ELK1 (MIM 311040) and ALAS2 (MIM
301300), to systematically screen 47 candidate genes for
mutations in families with overlapping linkage intervals.
This led to the identification of PQBP1 (MIM 300463),
which encodes the polyglutamine binding protein 1, and
FTSJ1 (MIM 300499), a human homolog of the Esch-
erichia coli 2′-O-rRNA methyltransferase FtsJ/RrmJ
gene, the first two XLMR genes found in Xp11 (Kal-
scheuer et al. 2003; Freude et al. 2004). In the present
study, we report the identification of seven different mu-
tations, in a novel brain-expressed gene, that are asso-
ciated with familial XLMR.
Subjects and Methods
Patients and Controls
Mutation screening was performed in 31 families with
XLMR and overlapping linkage intervals and in 179
unlinked families from the European XLMR Consor-
tium. All patients had a normal karyotype, and fragile
X syndrome was ruled out. The control panel included
312 unrelated healthy male controls. Samples from pa-
tients and their relatives as well as from controls were
obtained after receiving informed consent. A summary
of clinical data from all patients with mutations in
JARID1C is given in table A1 (online only).
In family N017, with four affected males (fig. 1A),
linkage studies had mapped the gene defect to the
DXS1003-PGK1P1 interval. The patients in this family
present with MR and microcephaly. The index patient,
III:14, was born on time with a weight of 1,750 g. He
was able to walk at the age of 14 mo and spoke his first
words at the age of 3 years. At the age of 41 years, at
his last clinical examination, his height was 165 cm
(!3rd percentile), his weight was 58.8 kg, and his head
circumference was 53.8 cm (∼3rd percentile). He showed
mild dysmorphisms, including small forehead, small eye-
lashes, prognathism, and small testes. His brother, pa-
tient III:2, was examined at the age of 53 years: his height
was 154 cm (!3rd percentile), and his head circumfer-
ence was 53.5 cm (∼3rd percentile). He has mild dys-
morphic features, including flat philtrum, thin upper lip,
prognathism, and a small penis. The third patient, IV:
4, was born on time with a weight of 2,500 g. He was
able to walk at the age of 2 years and spoke his first
words at the age of 3.5 years. His examination at the
age of 25 years (height 171 cm [∼25th percentile], weight
65 kg, head circumference 54 cm [∼3rd percentile]) also
showed mild dysmorphic features: small, deep-set eyes;
upslanting palpebral fissures; and micrognathia. How-
ever, his genitals were normal. At that time, his total IQ
was measured to be 70 (verbal 60, performance 86).
Clinical data were not available for patient III:16.
Linkage data and clinical findings for family L017 (fig.
1B) have been described elsewhere (Claes et al. 2000).
In this family, which has a syndromic form of XLMR,
four males in two generations present with severe MR,
slowly progressive spastic paraplegia, facial hypotonia,
and maxillary hypoplasia. Additional features are ag-
gressive behavior and strabismus.
In family D034 (fig. 1C), the two affected brothers
exhibit a severe form of MR. The index patient, II:4,
was born after an uneventful pregnancy. Developmental
delay was noticed at the age of 1 year. The patient shows
strabismus divergens. He understands spoken language
well, but the only word he speaks is “yes.” At the age
of 5 years, electroencephalogram examination revealed
abnormalities (groups of sharp theta/delta waves), but
epileptic seizures have never been observed. His behavior
is characterized by frequent unmotivated aggressive out-
bursts along with indolence. He has good memory skills
and can perform simple tasks such as shopping at the
local bakery. His older brother shows an almost identical
phenotype. In addition, he exhibits abundant body hair
and diastema of the teeth. Because of gallstones, the gall-
bladders of both brothers had been removed at the age
of 20 years and 31 years, respectively. No other medical
abnormalities have been noticed.
The two boys in family P018 (fig. 1D) have MR and
short stature (patient II:1, body height 105 cm at the
age of 6.5 years [!3rd percentile]; patient II:2, body
height 91 cm at the age of 4.5 years [!3rd percentile]).
Apart from strabismus and myopia in the younger
brother (II:2), no other clinical abnormalities have been
reported. The nonconsanguineous parents are clinically
inconspicuous.
In family N063 (fig. 1E), two brothers and their sister
have MR. They share a conspicuous phenotype of severe
MR, spasticity, epileptic seizures, short stature, micro-
cephaly, hypermetropia, and small feet. Both males have
cryptorchism. Additional symptoms include alopecia
areata in patient II:1. The sister (II:3) was described to
have an unstable mood disorder. The parents of these
children are distantly related.
In family D029, with two affected brothers (fig. 1F),
the index patient (II:3) has severe MR. His height (169
cm [∼3rd percentile]) and head circumference (59 cm
[∼97th percentile]) at the age of 22 years were in the
normal range. The testis volume was 25 ml (197th per-
centile), but there was no expansion of the CGG repeat
in the FMR1 gene. His older brother (II:1) is also affected
with a severe form of MR. Height (169 cm [∼3rd per-
centile]), head circumference (58 cm [∼97th percentile]),
and testis volume at the age of 25 years are normal, and
he has no additional abnormalities. The son of a half
sister (III:2) is said to suffer from learning impairment,
but no clinical details are available.
In family A034 (fig. 1G), four affected males have been
reported. Little is known about the early lives of the three
Figure 1 Mutations identified in the JARID1C gene in families N017 (A), L017 (B), D034 (C), P018 (D), N063 (E), D029 (F), and A034
(G). The sequence chromatograms of the index patients (asterisks) are shown beside the wild-type sequences. The corresponding pedigrees are
presented above the chromatograms. Family members who have been analyzed for sequence changes are numbered. For patients with numbers
in parentheses, only clinical data were available (no DNA was available for mutation analysis).
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affected brothers (III:1, III:2, and III:4) except that de-
velopment was slow and all were institutionalized in early
childhood. Patient III:4 died as a result of accidental
drowning at the age of 12 years. The two other brothers
(III:1 and III:2), now aged 61 years and 56 years, re-
spectively, reside in a group home. Both had short stature
(154 cm [!3rd percentile] and 156 cm [!3rd percentile],
respectively), with normal head circumferences (57 cm
[∼75th percentile] and 55 cm [25th–50th percentile], re-
spectively). Both were severely handicapped, and neither
spoke more than a few single words. Occasional short
outbursts of aggression were reported. In his 30s, patient
III:2 started to have generalized seizures about once a year,
which sometimes led to hospitalization. Their uncle (II:
4) is mildly handicapped and lives at home. Recent re-
examination of this patient revealed a very different phe-
notype, strongly suggesting a different disorder. He was
previously known as the “sunny boy” of the family and
had a “big head at birth, which had to be carried on a
pillow.” He did not walk until the age of 6 years, and,
later on, his walk was unsteady and awkward. He had
“plenty of speech, which was unclear.” Now 74 years of
age, he sits and smiles and is very unsteady on his feet.
He is of normal height, but he has a large head circum-
ference of 62 cm (197th percentile).
Mutation Analysis by Denaturing High-Performance
Liquid Chromatography (DHPLC)
For each patient, the complete JARID1C (Jumonji AT-
rich interactive domain 1C [MIM 314690]) coding se-
quence and ∼40 nucleotides of the neighboring intronic
sequences were amplified in 34 independent PCRs from
genomic DNA. All primer sequences and PCR product
sizes are given in table A2 (online only). In general, PCR
amplifications were performed in 20-ml reaction volumes
that contained 100 ng genomic DNA, 1# buffer (50
mM KCl, 15 mM Tris-HCl [pH 9.0], 2.5 mM MgCl2,
0.01% Tween 20), 0.2 mM of each primer, 100 mM
dNTPs, 0.5 M betaine (Sigma), 1 U Taq polymerase,
and 0.025 U Pfu polymerase. The PCR profile consists
of a touchdown PCR with an initial denaturing step at
96C for 3 min and then 20 cycles at 95C for 30 s,
65C for 30 s (lowered 0.5C at each cycle), and 72C
for 30 s, followed by 30 cycles at 95C for 30 s, 55C
for 30 s, and 72C for 30 s. The PCR was finalized by a
5-min extension at 72C. PCR products were checked by
1.5% agarose gel electrophoresis before they were sub-
jected to DHPLC by the WAVE nucleic-acid–fragment
analysis system (Transgenomic). For DHPLC, we pooled
PCR products from two patients. Melting profiles and
resolution temperatures were predicted by the Transgen-
omic WAVEMAKER software, version 4.1. Conditions
are available on request. PCR products that gave rise to
abnormal elution profiles either were gel purified by use
of the QIAquick gel extraction kit (Qiagen) and then sub-
jected to sequencing or were directly sequenced in both
directions by use of BigDye Terminator chemistry (PE
Biosystems). Separation was performed on an Applied
Biosystems 3730xl DNA Analyzer.
RNA Isolation and Northern Blot Analysis
Total RNA was isolated from patient and control lym-
phoblastoid cell lines by use of TRIzol (Invitrogen), in
accordance with the manufacturer’s protocol. Poly-A
RNAs, which were each obtained from 100 mg of total
RNA by use of Dynabeads (Dynal), were separated in a
formaldehyde-containing gel in 1#MOPS buffer, trans-
ferred to a Hybond N membrane, and crosslinked by
UV. A human multiple-tissue northern blot was obtained
from BioChain. The JARID1C (GenBank accession num-
ber L25270) and JARID1D (GenBank accession num-
ber NM_004653) probes corresponding to nucleotides
c.4563 to c.5292 (730 bp) and c.4400 to c.5128 (729
bp), respectively, were synthesized using the following
primer pairs: JARID1C (forward): 5′-GAACCAGAATG-
GCTTGGAAC-3′ and JAIRD1C (reverse): 5′-GGACTG-
AGGTGGTTGTGAGG-3′; JARID1D (forward): 5′-CTC-
GGAGCTCAGGGATTATG-3′ and JARID1D (reverse):
5′-GAGTCATGAAATTCTTGTTTTTCC-3′. The probes
were purified, and their sequences were verified. Subse-
quently, probes were labeled with 32[P]dCTP and were
hybridized to the blots in ULTRAhyb buffer (Ambion).
The blots were washed in accordance with the manufac-
turer’s protocol and were exposed to Fuji medical X-ray
films at80C for 6 h for up to 8 d by use of intensifying
screens. Autoradiograms were scanned using an Epson
Expression 1680 Pro scanner. To control for RNA load-
ing, blots were reprobed with a b-actin probe that was
provided by BioChain.
Results
Identification of JARID1C Mutations in Families with
XLMR
In a recent analysis of linkage data from published and
unpublished studies of families with NS-XLMR, we
showed that mutations involved in XLMR seem to cluster
in three distinct regions on the X chromosome (Ropers
et al. 2003). Therefore, we chose a 7.4-Mb interval on
Xp11.23-p11.21, flanked by the genes ELK1 and ALAS2,
to systematically screen 47 brain-expressed candidate
genes for mutations in families with overlapping linkage
intervals. One of these genes, JARID1C, was found to be
mutated in 2 of 31 families investigated. The JARID1C
gene contains 26 exons and encodes a member of a con-
served protein family, which carries several DNA-binding
motifs potentially involved in transcriptional regulation
and chromatin remodeling. In family N017, we found a
Ta
bl
e
1
Su
m
m
ar
y
of
Se
qu
en
ce
C
ha
ng
es
in
JA
R
ID
1C
Fo
un
d
in
Pa
ti
en
ts
w
it
h
M
R
N
uc
le
ot
id
e
C
ha
ng
e
A
m
in
o
A
ci
d
V
ar
ia
ti
on
Po
si
ti
on
Ty
pe
of
Se
qu
en
ce
C
ha
ng
e
Fa
m
ily
C
od
e
N
o.
of
L
in
ke
d
Fa
m
ili
es
w
it
h
Se
qu
en
ce
C
ha
ng
e
(
)
n
p
31
N
o.
of
U
nl
in
ke
d
Fa
m
ili
es
w
it
h
Se
qu
en
ce
C
ha
ng
e
(
)
n
p
17
9
Fr
eq
ue
nc
y
in
C
on
tr
ol
X
C
hr
om
os
om
es
c.
20
2_
20
3i
ns
C
R
68
fs
X
7
E
xo
n
2
Fr
am
es
hi
ft
m
ut
at
io
n
D
03
4
0
1
0/
31
2
c.
11
62
G
r
C
A
la
38
8P
ro
E
xo
n
9
M
is
se
ns
e
m
ut
at
io
n
N
01
7
1
0
0/
31
2
c.
12
04
G
r
T
A
sp
40
2T
yr
E
xo
n
9
M
is
se
ns
e
m
ut
at
io
n
A
03
4
0
1
0/
31
2
c.
20
80
C
r
T
A
rg
69
4T
er
E
xo
n
15
N
on
se
ns
e
m
ut
at
io
n
P0
18
0
1
0/
31
2
c.
20
92
G
r
A
G
lu
69
8L
ys
E
xo
n
15
M
is
se
ns
e
m
ut
at
io
n
D
02
9
0
1
0/
31
2
c.
21
91
C
r
T
L
eu
73
1P
he
E
xo
n
15
M
is
se
ns
e
m
ut
at
io
n
L
01
7
1
0
0/
31
2
c.
38
64
G
r
A
T
rp
12
88
Te
r
E
xo
n
23
N
on
se
ns
e
m
ut
at
io
n
N
06
3
0
1
0/
31
2
c.

23
9G
r
A
5′
U
T
R
In
tr
on
ic
al
te
ra
ti
on
0
1
0/
31
2
c.

90
G
r
A
5′
U
T
R
In
tr
on
ic
al
te
ra
ti
on
1
0
0/
31
2
c.
52
2
19
G
r
A
In
tr
on
4
In
tr
on
ic
al
te
ra
ti
on
3
3
9/
96
c.
56
4G
r
A
Ly
s1
88
Ly
s
E
xo
n
5
Si
le
nt
m
ut
at
io
n
0
3
3/
94
c.
17
64
G
r
A
G
ln
58
8G
ln
E
xo
n
13
Si
le
nt
m
ut
at
io
n
0
1
0/
31
2
c.
17
94
C
r
T
Pr
o5
98
Pr
o
E
xo
n
13
Si
le
nt
m
ut
at
io
n
0
2
0/
31
2
c.
22
43

11
G
r
T
In
tr
on
15
In
tr
on
ic
al
te
ra
ti
on
0
5
2/
96
c.
25
17
-7
_8
in
sT
A
C
In
tr
on
17
In
tr
on
ic
in
se
rt
io
n
0
1
0/
31
2
232 Am. J. Hum. Genet. 76:227–236, 2005
Figure 2 Northern blot analysis of poly-A RNA isolated from
lymphoblastoid cell lines obtained from six patients and five controls.
The blot was sequentially hybridized with a cDNA probe correspond-
ing to nucleotides 4563–5292 of JARID1C and with a b-actin cDNA
probe. Note the significant reduction of JARID1C transcript levels in
patients from families N063 and P018.
Figure 3 Sequential hybridization of JARID1C (A), JARID1D
(B), and b-actin (C) to a northern blot containing human poly-A
RNAs from adult heart, brain, liver, pancreas, skeletal muscle, and
lung. In panel A, probes correspond to nucleotides 4563–5292 of
JARID1C; in panel B, probes correspond to nucleotides 4400–5128
of JARID1D; and, in panel C, probes correspond to a cDNA fragment
of b-actin.
missense mutation, c.1162GrC, that resulted in an ala-
nine-to-proline exchange at amino acid 388 (fig. 1A). An-
other single-nucleotide substitution (c.2191CrT) was
identified in family L017; this substitution changed the
amino acid leucine into phenylalanine at position 731 (fig.
1B). Sequencing of PCR-amplified JARID1C transcripts
from available family members showed that, in both fam-
ilies, the respective mutations cosegregate with the disease
(data not shown). None of these changes was found in
312 male controls.
These findings prompted us to analyze 179 additional
unrelated patients from smaller families with established
or probable XLMR. In five of these families, we found
additional mutations, including one frameshift mutation,
two nonsense mutations, and two missense mutations. A
single-nucleotide insertion of a cytidine (c.202_203insC)
introduces a frameshift mutation in patients from family
D034 (fig. 1C), eventually resulting in a premature stop
codon at position 75 of JARID1C. In family P018, the
single-nucleotide substitution c.2080CrT replaces the
normal arginine by a termination codon at position 694
of the protein (fig. 1D). Another nonsense mutation
(Trp1288Ter) was identified in family N063 and is caused
by the sequence change c.3864GrA (fig. 1E). In family
D029, a guanine-to-adenine mutation (c.2092GrA) re-
sults in a glutamic acid–to-lysine exchange at amino acid
698 (Glu698Lys) (fig. 1F). The second missense mutation
found in the patient cohort that is present in family A034
(c.1204GrT) changes an aspartic acid residue into ty-
rosine at position 402 (fig. 1G).
Reinvestigation of the respective sequences in all avail-
able affected and unaffected family members confirmed
the cosegregation of the mutations with the phenotype
(data not shown). All the mutations that were identified
in these families were absent in the remaining 205 an-
alyzed patients with XLMR and also in 312 male con-
trols. In addition to the seven most likely disease-causing
mutations, we have found several other sequence vari-
ants that were not known before. However, these vari-
ants either were silent mutations or were found in in-
tronic sequences and, therefore, for the time being, were
not considered as disease causing. All sequence changes
found in patients with MR are listed in table 1.
Expression Analysis of JARID1C in Patients
To check the stability of all mutated transcripts, we
performed northern blot hybridizations of poly-A cell
line RNA from one affected male in each family (except
family A034) and five male controls. To avoid cross-
hybridization with the highly similar Y-chromosomalgene
JARID1D, probes were employed that did not show sig-
nificant sequence similarity to each other upon BLAST2
alignment. JARID1C transcripts were almost undetecta-
ble in the patients from families P018 and N063, who
had premature terminations at codon 694 and codon
1288 (fig. 2), respectively. Thus, the phenotype in these
patients most likely results from functional loss of
JARID1C protein. In contrast, no reduction was observed
in the patient from family D034, in whom a frameshift
mutation introduces a premature termination at codon
75 of JARID1C (fig. 2). In patients with missense mu-
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Figure 4 Schematic representation of the human JARID1C protein, showing the positions and types of mutations found. On the basis
of the NCBI Conserved Domain Database, the positions of known domains and motifs are marked by different boxes, which are explained at
the bottom of the figure.
tations, JARID1C RNA levels were not conspicuously
changed.
JARID1C Is Mainly Expressed in Brain and Skeletal
Muscle
A predominant transcript of ∼6.0 kb was detected in
almost all of the human adult tissues investigated, al-
though at very different levels. The strongest expression
was observed in brain and skeletal muscle, whereas the
lowest expression was seen in heart and liver (fig. 3A).
Hybridization of a JARID1D-specific probe to the same
blot showed expression that was much lower than that
of JARID1C in general, and expression was seen only
in pancreas, lung, brain, and skeletal muscle (fig. 3B).
The JARID1C Protein Contains Several Conserved
DNA-Binding Domains
JARID1C (GenBank accession number P41229) en-
codes a 1,560-aa protein that is homologous to three
other proteins of the human JARID1 family. On the basis
of a BLAST2 alignment, the amino acid identity of
JARID1C to JARID1D (GenBank accession number
NP_004644), JARID1A (GenBank accession number
NP_005047), and JARID1B (GenBank accession num-
ber NP_006609) is 85%, 51%, and 47%, respectively.
Human JARID1C is evolutionarily conserved, with
homologs in the mouse (Jarid1c [GenBank accession
number NP_038696]), fruit fly (Lid [GenBank acces-
sion number NP_723140]), and nematode (ZK593.4
[GenBank accession number CAA93426]) that show
94%, 42%, and 34% amino acid identity, respectively.
A Conserved Domain Database alignment (Marchler-
Bauer et al. 2003) revealed several conserved domains
between the JARID proteins, including a JmjN domain
(smart00545), an Arid/Bright domain (smart00501), a
JmjC domain (smart00558), a C5HC2 zinc-finger do-
main (pfam02928), and PHD zinc-finger domains
(pfam00628) (fig. 4 and data not shown).
Discussion
We have shown that patients affected with XLMR carry
mutations in a novel XLMR gene, JARID1C. Mutation
screening in 210 unrelated families with XLMR revealed
at least seven different sequence alterations that are most
likely disease causing—including two nonsense muta-
tions, one frameshift mutation, and four missense mu-
tations. The three mutations that introduce premature
termination codons are expected to remove 195%,
155%, and 117% of the normal protein, respectively.
Moreover, in the two families with the longest residual
transcripts, P018 and N063, JARID1C expression was
almost undetectable, probably because of the mechanism
of nonsense-mediated mRNA decay (NMD) (Holbrook
et al. 2004), suggesting a complete loss of JARID1C
function in these two families. However, the frameshift
mutation in family D034, which truncates the JARID1C
protein at position 75, seems to be insensitive to NMD.
Similar findings have been reported elsewhere (Asselta
et al. 2001), including intertissue (Bateman et al. 2003)
and interindividual (Kerr et al. 2001) variations in NMD
efficiency. In family D034, the aberrant phenotype may
be a result of either extreme shortening of the protein
and deletion of nearly all relevant domains or an ab-
normal protein produced by alternative usage of a me-
thionine downstream of exon 2.
All missense changes affect amino acids, which are
identical in the four different members of the human
JARID1 family and in homologous proteins of mouse
and fruit fly, suggesting an important functional role
for these amino acids (fig. 5). The missense change
Leu731Phe (family L017), which is located in a pre-
dicted, evolutionarily conserved C5HC2 zinc-finger
domain, might have a profound effect on that domain
as a result of the differences in size and chemical prop-
erties of leucine and phenylalanine. Although the three
other missense changes—Ala388Pro, Asp402Tyr, and
Glu698Lys—are not located in a conserved domain,
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Figure 5 Partial amino acid sequence alignment of the four different members of the human JARID1 family (Hs_JARID1A–Hs_JARID1D),
the JARID1C orthologous protein of mouse (Mm_Jarid1c), and the homologous Lid protein of fruit fly (Dm_Lid). Amino acids that differ from
the JARID1C sequence are highlighted. The four missense mutations and their positions are indicated by arrows and bold letters. The respective
amino acids are identical in the six proteins.
they can cause considerable changes in the protein struc-
ture. The introduction of a proline residue causes the
protein backbone to bend. The replacement of aspartic
acid by tyrosine, as well as of glutamic acid by lysine,
alters the charge of the protein and, presumably, its
three-dimensional structure. Together, our data suggest
that the seven JARID1C mutations detected affect the
function of the protein and are responsible for the cog-
nitive defects found in the patients studied.
Human JARID1C/SMCX protein—which contains
several highly conserved domains, including Arid/Bright
and Jumonji—belongs to the JARID1 subfamily of
ARID DNA-binding proteins (Kortschak et al. 2000;
Wilsker et al. 2002). Apart from JARID1C, three other
proteins that are characterized by a core ARID of 81
aa—namely, JARID1D/SMCY, JARID1A/RBBP2, and
JARID1B/PLU-1—comprise the JARID1 subfamily.
JARID1A/RBBP2 was cloned in a search for retino-
blastoma protein (pRB)–binding partners (Fattaey et al.
1993). pRB is a well-known and extensively character-
ized protein that regulates cell proliferation by inhib-
iting growth-promoting proteins. It can recruit histone
deacetylase to chromatin (Luo et al. 1998), which re-
presses the transcription of genes involved in cell-cycle
regulation that contain sites for the E2F transcription
factor in their promoters (Dyson 1998). The JARID1B
protein, also known as “PLU-1,” is a transcriptional
repressor. It binds brain factor 1 (BF1), also known as
“FOXG1B,” and paired box 9 (PAX9), both of which
are developmental transcription factors (Tan et al. 2003).
In mouse embryos and human fetal brain, the expres-
sion of BF1/FOXG1B is restricted to the neuronal cells
in the telencephalon, with strong expression in the de-
veloping dentate gyrus and hippocampus. In Foxg1-
null mice, the generation of the earliest born neurons,
the Cajal-Retzius cells, is suppressed (Hanashima et al.
2004).
JARID1C/SMCX and JARID1D/SMCY (MIM
426000) constitute an X-Y homologous gene pair, which
probably evolved from an identical gene pair on the orig-
inal mammalian (proto-) sex chromosomes (Delbridge
et al. 2004), implicating a functional equivalence of
JARID1C and JARID1D. This probable similar func-
tion of X and Y copies is strengthened by the fact that
the human (as well as the mouse) JARID1C gene was
thought to escape X inactivation (Agulnik et al. 1994).
However, the mouse Jarid1c gene exhibits partial X in-
activation in embryos, in extraembryonic lineages, and
in different adult tissues, showing an expression of 20%–
70% from the inactive X allele, compared with the active
X allele (Sheardown et al. 1996). Furthermore, Jarid1c
and Jarid1d are expressed in mouse brain in a sex-specific
fashion (i.e., in adulthood, Jarid1c is expressed at a level
that is significantly higher in female brains than in male
brains, and the expression of Jarid1d in males is not
sufficient to compensate for the female bias in X-gene
expression [Xu et al. 2002]). Hence, the X-Y gene pair
JARID1C/JARID1D might not be functionally equiva-
lent, suggesting an indispensable role of JARID1C for
normal brain function. Together with other differentially
regulated X-Y gene pairs (e.g., USP9X/Y [MIM 300072
and MIM 400005], RPS4X/Y [MIM 312760 and
MIM 470000], and UTX/Y [MIM 300128 and MIM
400009]), JARID1C/JARID1D might also be involved
in sex differences in brain development and function and
in the prevalence of neuropsychatric disorders (Vawter
et al. 2004).
We have found mutations in the gene JARID1C in 7
of 210 families with XLMR, which corresponds to a
mutation frequency of 3.3% (CI 0.009–0.057) for
XLMR. This number is somewhat biased, since families
with XLMR with linkage intervals outside the candidate
region in Xp11 have been excluded from our mutation
screen. However, the mutation frequency is still 2.8%
(CI 0.004–0.052) if only the five changes found in 179
families with proven or probable XLMR are taken into
account. Thus, JARID1C seems to be one of the more
frequently mutated genes in patients with XLMR, and
its mutation frequency is comparable to that described
for the creatine transporter SLC6A8 (MIM 300036)
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(Rosenberg et al. 2004). JARID1C mutations cause not
only nonsyndromic but also syndromic XLMR, as seen
in families N017, L017, and N063; this is in agreement
with findings in other XLMR genes (Merienne et al.
1999; Meloni et al. 2000; Bienvenu et al. 2002; Strømme
et al. 2002; Kalscheuer et al. 2003).
We conclude that mutations in JARID1C contribute
significantly to the etiology of XLMR. Further studies
will include the characterization of mice deficient in
Jarid1c and expression profiling of the brain tissues.
These investigations should shed more light on the
mechanisms by which mutations in JARID1C result in
dysfunction of the brain.
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